Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Celyad S.A.
DescriptionAllogeneic therapy using adipose-derived mesenchymal stem cells (MSCs) acquired from a stem cell bank
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPreclinical
Standard IndicationMyocardial infarction (MI)
Indication DetailsTreat acute myocardial infarction (AMI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today